Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
产品详情
Peptide T是源自HIV-1 gp120的V2区的八肽。 Peptide T是 CD4 受体的配体,可阻止 HIV 与CD4受体结合。
生物活性
Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a ligand for the CD4 receptor and prevents binding of HIV to the CD4 receptor.
性状
Solid
IC50 & Target[1][2]
CD4, HIV
体外研究(In Vitro)
Peptide T acts to block viral entry as it inhibits in the MAGI cell assay and blocks infection in the luciferase reporter assay using HIV virions pseudotyped with ADA envelope. Peptide T selectively inhibits HIV replication using chemokine receptor CCR5 compared to CXC4. Peptide T at 10 M induces IL-10 production by the human Th2 cell line and PBMC. Also peptide T at 10 M concentration significantly inhibits IFN-g production by PBMC. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Peptide T is administered subcutaneously at different doses and phases of the experimental autoimmune encephalomyelitis (EAE) disease, but Peptide T neither prevents nor ameliorates EAE. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
ClinicalTrial
SequenceShortening
ASTTTNYT
Sequence
Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr
参考文献
[1]. Ruff MR, et al. Peptide T[4-8] is core HIV envelope sequence required for CD4 receptor attachment. Lancet. 1987 Sep 26;2(8561):751.[2]. Ruff MR, et al. Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5). Antiviral Res. 2001 Oct;52(1):63-75.[3]. Raychaudhuri SP, et al. Immunomodulat
溶解度数据
In Vitro: H2O : 100 mg/mL (116.57 mM; Need ultrasonic)配制储备液